Matthew Sherman

Matthew Sherman possesses extensive experience in the pharmaceutical industry, currently serving as Executive Vice President and Chief Medical Officer at Deciphera Pharmaceuticals since 2019. Previously, Matthew held the position of Chief Medical Officer at Acceleron Pharma from 2006 to 2018 and at Synta Pharmaceuticals from 2004 to 2006. Earlier roles include Therapeutic Area Director for Oncology at Wyeth and Senior Director at Genetics Institute. Matthew's educational background includes a B.S. in Chemistry from the Massachusetts Institute of Technology and an M.D. from the Geisel School of Medicine at Dartmouth, complemented by a significant tenure at the Dana-Farber Cancer Institute from 1983 to 1992.